Practical and Interactive a Virtual Conference “LUNG SYMPOSIUM on 23rd Feb 2022.
Cancer that begins in the lungs and most often occurs in people who smoke. Two major types of lung cancer are non-small cell lung cancer and small cell lung cancer. Causes of lung cancer include smoking, second-hand smoke, exposure to certain toxins, and family history. Symptoms include a cough (often with blood), chest pain, wheezing, and weight loss. These symptoms often don’t appear until the cancer is advanced. Treatments vary but may include surgery, chemotherapy, radiation therapy, targeted drug therapy, and immunotherapy.
A Webinar on the topic “LUNG SYMPOSIUM, Forum for the exchange of knowledge and ideas about new standards of Care, Advances in the treatment of LUNG Cancer” was organized by Dr. Amit Kumar Senior Consultant, Jayprabha Medanta Hospital, Patna, invited speaker Dr. Ullas Batra, New Delhi, Professor Kumar Prabhas, and Panelist Dr. Rushabh Kothari, Ahmedabad, Dr. Raajit Chanana, Delhi, Dr.Sudeep Das Kolkata, Dr.Ventrapati Pradeep, Vizag, Dr. Amit Agarwal, Raipur, Dr.Anshul Agarwal, Surat, Dr.Yashwant Kashyap, Raipur, Dr.Amit Chaudhary, Varanasi, Dr.Anuj Gupta, Varanasi, Dr.Lakhan Kashyap, Varanasi, Dr.Bipinesh Sansar, Varanasi, Dr.Tanmoy Mondal, Kolkata, Dr.Sunil Chopade, Mumbai on 23rd February 2022 at 7.00 P.M.
Dr. Ullas Batra Co-Director, Dept Of Medical Oncology Chief, Thoracic Medical Oncology Rajiv Gandhi Cancer Institute and Research Center Delhi discussed baseline testing in a patient with advanced NSCLC(Non-Small-Cell Lung Cancer) -Current Recommendation, NSCLC is any type of epithelial lung cancer other than small cell lung cancer (SCLC). The most common types of NSCLCare squamous cell carcinoma, large cell carcinoma, and adenocarcinoma, but several other types occur less frequently, and all types can occur in usual histologic variants.
Dr. Amit Kumar, Jayprabha Medanta Hospital, Patna, discussed Immunotherapy in 1 L mNSCLC focus on Tecentriq.
Cased based discussion on optimizing treatment options in 1L mNSCLC was taken by Dr. Prabhash, Tata Memorial Hospital, and Informative sessions on Alectinib in ALK+NSCLC lung cancer taken by Dr. Akhil Kumar Tata Memorial Hospital, Varanasi
Dr. Charu Bahl, Manager of Scientific Affairs, Medgenome Labs discussed Genomics in Lung Cancer.
.
Recent Comments